Projects
Working in more than 50 countries, The Health Policy Partnership has developed highly credible resources that help inform policymakers about key health issues and contribute to bringing about a step change in discussions and decisions in health policy.
Kathy Barnard‘HPP is an organised, experienced team with an unprecedented focus on communication and collaboration. They coordinate activity with a flexible approach to the fluctuations in needs of project tasks and participants, while maintaining momentum toward the objective at hand. They are detail-oriented and timely with responses, and they truly comprehend the perspectives of stakeholders with whom they work in any given aspect of health policy research and strategy.’
Rethinking MS
Multiple sclerosis is a neurological disorder that places unique challenges on health and social care systems, which must work together to ensure the needs and goals of every person with MS are met.
A life-course approach to immunisation
Programmes that support immunisation across the life course can improve population health and promote health system sustainability. International examples of best practice offer valuable lessons.
Non-alcoholic steatohepatitis
The progressive form of non‑alcoholic fatty liver disease, known as non‑alcoholic steatohepatitis (NASH), is a growing concern as the global prevalence of obesity and type 2 diabetes continues to rise.
Genetic testing for BRCA mutations
Genetic mutations in the BRCA1 and BRCA2 genes are associated with a significant risk of developing breast cancer, but many people who may carry these mutations cannot access genetic testing.
A sustainable approach to depression
Depression is on the rise, and the policy response has so far been insufficient, with huge gaps in care and underfunding of mental health services.
Atrial fibrillation and AF‑related stroke
Atrial fibrillation is a common condition and leading cause of stroke, yet is widely under-recognised and people across Europe face significant inequalities in access to detection and treatment.
Radiotherapy
As the incidence of cancer increases, healthcare systems must find effective and sustainable ways to care for all cancer patients – and radiotherapy is a key part of this.
Viral hepatitis in Asia Pacific
Global deaths from viral hepatitis continue to rise, and more than 60% occur in the Asia Pacific region.
Life-course vaccination
Vaccination is vital to improve population health throughout life – but despite strong evidence, it is misunderstood and undervalued.
Childhood epilepsy
The needs of children with epilepsy who experience prolonged convulsive seizures have been neglected – but these children may be at serious risk without effective treatment.
Sarcoma Policy Checklist
Despite advances in research and treatment in recent years, sarcoma patients report some of the poorest experiences of care among people with cancer.
Rare Diseases: shaping a future with no-one left behind
Rare diseases affect up to 400 million people across the world – and, for many, there are no treatment options available.
All.Can – changing cancer care together
All.Can is an international initiative working to improve efficiency in cancer care by focusing on what matters to patients.
RARECAREnet
Rare cancers represent almost a quarter of new cancer diagnoses in Europe – so improving patient outcomes should be a public health priority.
The state of play in person-centred care
A person-centred approach can transform a person’s experience of care, but a lack of common definitions and terminology may hinder its use in practice.
Metastatic breast cancer country reports
Despite great improvements in diagnosis and treatment, breast cancer remains the most frequent cause of cancer death in women worldwide.
Immuno-Oncology
Using the body’s own immune system to fight disease, immuno-oncology has transformed the prognosis for many types of cancer.
The Heart Failure Policy Network
HFPN is an independent, multidisciplinary network working across Europe to raise awareness of the unmet needs of people with heart failure.